---
$id: https://graph.org.ai/products/commodity/51131751
$type: Product
source: UNSPSC
code: "51131751"
title: "Ozagrel hydrochloride"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ozagrel hydrochloride

**UNSPSC Code**: 51131751
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an enzyme inhibitor and antiplatelet agent with the molecular formula C13H12N2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W222U960HS, chemically known as (2e)-3-[4-(1h-imidazol-1-ylmethyl)phenyl]-2-propenoic acid hydrochloride, but more generally known as ozagrel hydrochloride, which bears US NIH Compound Identifier 5282439. European Medicines Agency schedules ozagrel hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09581MIG. Most nations, for tariff purposes, schedule ozagrel hydrochloride under HS 29332990. SMILES: C1CC(CCC1CN2CCNC2)/C=C/C(=O)O.CL.

